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Abstract The crystal structure of the neurotoxic phospholipase 
A2 , notexin, revealed three binding sites for sulphate ions which 
were suggested to be phosphate binding sites of importance for 
the activity of the toxin. The present investigation shows that the 
sulphate ion bound to the major binding site alters the structure 
of residues 60-75. In the absence of sulphate and phosphate, the 
structure of this loop has a conformation which partly resembles 
the non-neurotoxic PLA2s. The affinity of notexin for phosphate 
is 17 nM, as measured by the increase in fluorescence at 345 nm. 
Since the concentrations of phosphate and sulphate ions in blood 
plasma are 3 and 1 mM, respectively, the binding site must be 
occupied under physiological conditions. This major sulphate/ 
phosphate binding site explains the specific affinity labelling by 
pyridoxal phosphate. Pyridoxal phosphate binds to this anion 
binding site which allows the reaction with Lys-88 or Lys-89. The 
structure of notexin in the presence and absence of Ca2 + shows 
only small local structural differences. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The venom of the Australian tiger snake Notechis scutatus 
scutatus contains a number of different proteins. Among the 
various proteins are the neurotoxic phospholipases A2 (PLA2) 
that are well characterized exemplified by notexin and note-
chis II-5 [1-3]. Notexin is a myotoxic (muscle degenerative), 
presynaptically active neurotoxic PLA 2 . It is a basic, mono-
meric protein consisting of 119 amino acid residues cross-
linked by seven disulphide bridges. Notexin impairs the re-
lease of acetylcholine from cholinergic synapses [4-6] and 
causes rapid death through asphyxiation. The toxicity of note-
xin is dependent upon its PLA 2 activity [7]. 
Although the sequences of more than 50 different phospho-
lipases (PLA2s) are known and the structures of approx. 15 
PLA 2 s have been solved it is difficult to deduce the basis for 
their special functions by merely comparing their sequences or 
structures. Notexin is the only neurotoxic PLA 2 for which the 
structure has been solved [8]. The crystal structure of notexin 
is similar to those of other PLA 2 s and it does not seem to be 
significantly different from the non-neurotoxic ones apart 
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Abbreviations: PLA2, phospholipase A2; PLP, pyridoxal phosphate. 
from lacking the extra cc-helix, amino acid residues (62-66) 
which is present mainly in pancreatic phospholipases, e.g. bo-
vine pancreatic PLA 2 [9,10]. 
It is well known that all PLA 2 s are dependent on Ca
2 + for 
activity, but nothing has been published about a dependence 
on other ions. Therefore, we have as a first step toward elu-
cidating the importance of this anion-binding site measured 
the affinity of notexin for phosphate ion and compared the 
structure of notexin in the presence and absence of phosphate 
and calcium ions, respectively. The main anion binding site 
explains the specific modification of Lys-88 and Lys-892 with 
pyridoxal phosphate. 
2. Materials and methods 
2.1. Binding assay 
The affinity of notexin for phosphate was measured by the increase 
in fluorescence at 345 nm. Quantitative measurements of binding of 
phosphate were carried out with an Aminco spectrofluorometer 
equipped with a 500 W xenon lamp. The excitation wavelength was 
280 nm and the emission was scanned between 250 and 450 nm. The 
bandwidth in both cases was 5 nm. The sample contained 1.4 |iM 
toxin purified as described [1] and the phosphate concentration was 
varied from 1 to 1000 |j,M in a total volume of 1.5 ml 0.1 M NH4Ac, 
pH 7.4. In this assay, tryptophan was used as the reporter group [12]. 
Treatment of the binding data was performed with a program using 
the algorithm of Marquart [13,14]. 
2.2. Modification with pyridoxal phosphate 
15.5 mg ( » 1 |imol) lyophilized notexin, dissolved in 0.75 ml de-
gassed 50 mM /V-ethylmorpholine-HAc pH 7.5, was mixed in a 3 ml 
glass vessel with stirring (reacti vial) with 500 |j.g (~2 u,mol) PLP 
dissolved in 100 (il of the same buffer. After 40 min in room temper-
ature, 100 |il 0.2 mM (20 umol) NaBH in 1 mM NaOH was added 
and the reaction proceeded in 10 min. The modified notexin was 
desalted on a PD-10 column equilibrated in 50 mM NELtAc pH 6.7 
and lyophilized. 
2.3. Analysis of modified notexin 
For purification, the modified notexin was dissolved in 2 ml 50 mM 
NH4AC, pH 5.0 and applied on a SP-Sephadex-25 cation exchanger 
equilibrated in 50 mM NH4AC, pH 5.O. Elution was performed with a 
linear gradient 0.5 1 buffer A vs 0.5 1 buffer B. Buffer A: 50 mM 
NH4Ac, pH 5.0, and buffer B: 1 M NH4Ac, pH 5.O. From the spectra 
of the observed fractions and the molar extinction coefficient of pyr-
idoxal lysine at 325 nm (6325 = 10 000 [15]) it was possible to distin-
guish between mono- and di-derivatives. The fraction of interest was 
lyophilized and reduced and carboxymethylated with iodoacetic acid 
according to a standard procedure. 
4 mg of the desalted and lyophilized RCM-notexin was dissolved in 
1 ml 0.1 M NH4HCO3, pH 8.7, and mixed with 40 ul (1 mg/ml in 
water) Staphylococcus V-8 protease. After 3 h at 37°C under contin-
uous stirring, an aliquot (75 (il) was removed and acidified with 40 JJ.1 
'-The numbering is in accordance with Renetseder et al. [11]. 
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50% HAc. The reaction was complete according to HPLC analysis 
and the sample was lyophilized. The peptides were separated on a 
Vydac 4.8x250 mm RP-HPLC column and detected at 280 and 
325 nm. The peptide containing the pyridoxal group was sequenced 
on an automated sequencer model ABI 476A according to the man-
ufacturer's instructions. 
2.4. Modelling of pyridoxal phosphate binding 
Modelling of pyridoxal phosphate at the major sulphate/phosphate 
binding site was performed on a Silicon Graphics workstation using 
the O program [16]. The co-ordinates for other phospholipases than 
notexin were obtained from the Brookhaven protein data bank. The 
alignment of the different structures was achieved by superposing the 
a-helices C and E [9]. 
2.5. Structure determination of notexin in the presence of calcium ion 
Notexin purified as described [1] was crystallized using hanging 
drops according to a slightly modified protocol described elsewhere 
[8]. In addition to this protocol, CaSC>4 was added to a final concen-
tration of 5 mM. The crystals were trigonal of space group P3i21, and 
were isomorphous with Ca-free crystals of notexin with the cell di-
mensions a = b = l\.l A and c = 48.9 A. A 91% complete data set to 
2.1 A resolution was collected. The structure was refined using the Ca-
free structure as starting model using X-plor [17]. The final R factor 
for the reflections to 2.1 A resolution was 16.9% and the Rfla, 22.9%. 
2.6. Structure determination of notexin in the absence of 
sulphatelphosphate 
Notexin purified as described [1], with an additional ion-exchange 
step on an LKB GlasPack SP-5PW 8X75 mm TSK column, was 
crystallized using hanging drops. Crystals grew when a protein solu-
tion with half of the precipitant concentration of the well was equili-
brated against a 12% PEG 6000 solution in 0.4 M NH4C1 containing 
2% dioxane and buffered with 50 mM CHES at pH 9.O. 
The diffraction data were collected on an i?-axis imaging plate 
system mounted on a Rigaku rotating anode. 55 frames with 2° os-
cillation were collected and the data were processed using Denzo [18] 
and scaled using the program ScalePack [18]. The overall complete-
ness of the data was 92.5%. to 2.3 A and between 2.38 and 2.30 A it 
was more than 90%> complete for reflections over la. The _Rsym for the 
data is 5.4%> with more than 70% of the reflections observed more 
than once. The data were truncated using the CCP4 [19] suite of 
programs. 
The crystals belong to the monpclinic space group P2i with the cell 
dimensions a = 39.5 A, è = 36.6 À, c = 42.6 À and ß = 117.0°, unlike 
notexin crystals grown in ammonium sulphate, which belong to the 
trigonal space group P3i21. The present structure has one molecule in 
the asymmetric unit. 
The structure was determined by molecular replacement using the 
program Amore [20] using the refined notexin structure as the search 
model. The complete protein model was used, but without hetero 
Fig. 1. A model of the pyridoxal phosphate fitting into the P-loop of notexin showing the binding distance between the Ramino group of Lys-
88 and the carbon of the pyridoxal phosphate group. 
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Fig. 2. Comparison of the notexin structure in the absence (A) and presence (B) of calcium ion. 
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atoms. All refinement was done using the program X-plor [17], The 
Engh and Huber [21] parameters were used for refinement. A map 
calculated at this stage indicated that three regions in the structure 
were different; around residues 88 and 65 and around the calcium-
binding region (residues 28-32). These regions were omitted and a 
round of refinement was performed (positional refinement, simulated 
annealing followed by temperature factor refinement). 
The main chains of two of these regions were visible in the resulting 
electron density map. However, residues 87-89 did not show up. Fur-
ther refinement was continued with all reflections in the range of 15-
2.3 A resolution. 
The final R factor is 20.4% for all reflections, including 80 water 
molecules. Residues 87-89 continue to have high B factors and there 
seems to be no obvious density for these residues. The Ramachandran 
plot has 91% of the residues in the most favoured region and the 
remaining 9% in the additional allowed regions. The structure has a 
good stereochemistry with bond length deviation of 0.01 A and bond 
angle deviation of 1.4°. The co-ordinates and structure factors have 
been deposited in the PDB. 
3. Results 
3.1. Titration with phosphate 
From the uncorrected fluorescence spectrum, the photomul-
tiplier output at 345 nm was plotted vs. phosphate concen-
tration. This gave a 5 m a x of 76 uM (o = 4) and a Kd of 17 uM 
(o = 4). The data were not consistent with two binding sites. 
The emission peaks were well gathered around 345 nm with-
out any blue shift. The increase in intensity was approx. 20% 
upon titration. 
3.2. Modification with pyridoxal phosphate 
Chemical modification is one approach to deduce the func-
tion of a protein and pyridoxal phosphate, vitamin B6, is one 
of the reagents used for lysine modification [22]. Pyridoxal 
phosphate is a coenzyme participating in a variety of reac-
tions, e.g. transamination, decarboxylation and modification 
of amino acid side chains. The function of pyridoxal phos-
phate is the same in all known reactions. It reacts with amino 
groups to form a reversible, planar Schiff base intermediate. 
This Schiff base can be reduced with sodium borohydride to 
form a stable compound. 
The modified protein was purified on a SP-Sephadex 25 
column and three peaks could be detected. The 280/325 nm 
absorption ratio for the first peak was 1.8 and for the second 
3.0 which is close to the theoretical value for a mono-deriva-
tive. Reverse-phase chromatography following digestion of 
the second peak with Staphylococcus V-8 protease showed 5 
peaks when detected at 280 nm, only one of which absorbed 
at 325 nm. Sequencing of the peak containing pyridoxal-lysine 
showed that the signals for Lys-88 and Lys-89 were weakened 
but not completely absent. 
3.3. Pyridoxal phosphate labelling 
The modelling of pyridoxal phosphate in the major binding 
site in the notexin structure was readily carried out with a 
minimum of changes of any side chain. There were three 
possible ways to superimpose the phosphate of pyridoxal 
Fig. 3. Superposition of residues 53-91 of different phospholipase A2 structures. Notexin in the presence of phosphate (red) and absence (blue) 
and three other class I phospholipases in yellow. 
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Table 1 
Deviation of main chain nitrogen (N), main chain carbon (Ca), 
main chain carbon (CO), carbonyl oxygen (O) and the gamma car-
bon (Cy) in notexin in the presence and absence of calcium ion 
N(A) 
0.6 
0.5 
0.8 
3.8 
3.4 
1.7 
0.9 
<0.3 
Coe(A) 
0.6 
0.5 
1.0 
4.2 
3.6 
0.9 
0.7 
<0.3 
CO (A) 
0.6 
<0.5 
1.6 
4.5 
2.4 
0.8 
0.8 
<0.3 
0 ( A ) 
0.6 
0.5 
1.9 
5.7 
3.3 
0.7 
1.0 
<0.3 
Cy 
-
-
-
-
-
-
-
0.4 
phosphate on the tetrahedral sulphate ion in the notexin 
structure. Two of these alternatives required considerable dis-
tortion of the pyridoxal phosphate molecule and were less 
probable. The third alternative gave an almost relieved con-
formation of the pyridoxal phosphate molecule and required a 
minimum of rebuilding of the neighboring side chains (Fig. 1). 
3.4. Structure determination of sulphate I phosphate free notexin 
Comparison of the notexin structure in the absence and 
presence of sulphate shows that the only significant difference 
is the region 60-75. In addition, there is also a small change in 
the calcium loop. In the absence of sulphate, residues 87-90 in 
the major sulphate/phosphate binding site lacks electron den-
sity and it is not possible to determine the location of these 
residues. The positions of the backbone atoms of residues 60-
75 differ by approx. 2 A. 
3.5. Structure determination of notexin in the presence of Ca2+ 
In the presence of Ca2+ ion, the calcium-binding loop is 
more compact and the involved residues are centred around 
the Ca2+ ion. The carbonyl oxygens of residues 28, 30 and 32 
and the side chain of Asp-49 form a cage around the Ca2+ ion 
similar to the Ca2+ binding site in pancreatic phospholipases 
[10] (Fig. 2). Some of the Ca atoms of the involved residues 
differed as much as 4.2 A as compared to the structure with-
out Ca2+ ion (Table 1). Apart from these local differences at 
the Ca2+ binding loop, no other changes were detected. 
4. Discussion 
The only significant difference between the notexin struc-
tures with and without divalent anions is in the sequence of 
residues 60-75, which is obviously flexible. This may, at first 
glance seem trivial, but these changes occur in an interesting 
area. All known PLA2 structures described so far are similar 
and the differences between them seem to be evenly spread. 
However, between residues 60 and 75 the different structures 
seem to coincide. This is also valid for notexin without a 
phosphate or sulphate ion. When the PLA2 structures are 
compared with notexin containing sulphate, the structures 
are significantly different for residues 60-75 (Fig. 3). Since 
notexin is the only neurotoxic PLA2 for which the structure 
has been solved, it is tempting to propose that the neurotox-
icity is related to these differences. 
The lack of density for the residues at the major anion 
binding site indicate a flexible structure of the involved resi-
dues. It is likely that the structure containing a quaternary ion 
is the physiological relevant molecule and that the ion will 
stabilise the structure of the binding loop and thereby alter 
the position of its neighbour structure, i.e. residue 60-75. 
The sulphate-binding residues consist of Asn-86 and the 
three main-chain nitrogen atoms of residues 87, 88 and 89. 
This loop is short in comparison with the phosphate-binding 
loops (P-loops) of other proteins described earlier. In protein 
tyrosine phosphatases (PTP) the P-loop consists of 8 residues 
which are directly involved in the phosphate binding. The 
consensus sequence for the P-loops of different PTP is 
CXXXXXR [23]. In ATP- and GTP-binding proteins, e.g. 
elongation factors, adenylate kinases and phosphoglycerate 
kinases the consensus sequence of the P-loop motif is 
GXXXXGK(TS) [24]. 
We have known for many years that the reaction of notexin 
with pyridoxal phosphate only modified one or two lysines 
out of 11 and that the modified notexin retained all of the 
activities of the native protein (unpublished observation). Pyr-
idoxal itself does not react with notexin under the same con-
ditions because of the lack of the handle, the phosphate moi-
ety, even at 10-fold higher concentration. Modelling of 
pyridoxal phosphate to the major anion site in notexin 
showed no steric hindrance (Fig. 1). Only minor displace-
ments of the side chains were necessary to position the pyr-
idoxal moiety suitable for reaction with the Ramino group of 
Lys-88 or Lys-89. These two alternatives could not be discri-
minated. This confirms the observation from the sequencing 
data which seemed to indicate partial modification of both 
lysines. The ease with which the PLP could be introduced 
into the structure without formation of any constraints ex-
plains why the modified notexin retains its activities. 
A calcium ion is known to stabilize bovine PLA2 and to 
protect it from degradation by trypsin and from modification 
by p-bromophenacyl bromide and this has been attributed to 
structural changes [25]. This observation is not simply ex-
plained just by comparing the structure of notexin in the 
presence and absence of calcium ions. The two structures 
have the same flexibility as judged from the B factors, and 
apart from the calcium loop the structure is intact. The 
change in conformation of the calcium loop does not seem 
to influence the residues or the structure in the vicinity or 
form any long-range interactions. 
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